1. Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response‐Directed High‐Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy). Issue 6 (17th February 2016) Authors: Vivekanandan, Sindu; Breene, R.; Ramanujachar, R.; Traunecker, H.; Pizer, B.; Gaze, M. N.; Saran, F.; Thorp, N.; English, M.; Wheeler, K.; Michalski, A.; Walker, D. A.; Saunders, D.; Cowie, F.; Cameron, A.; Picton, S.; Parashar, D.; Horan, G.; Williams, M. V. Journal: Pediatric blood & cancer Issue: Volume 63:Issue 6(2016) Page Start: 1125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1420 iCARE: sarcoma patient radiotherapy experience during COVID-19. (August 2021) Authors: McCabe, H.; Nixon, I.; Abraham, A.; Cowie, F.; Reeds, H. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1602 Role of clinical networks in sarcomas: The Scottish Sarcoma Network(SSN)Experience. (April 2019) Authors: Nixon, J.; Cowie, F.; White, J.; Chong, P.; Lo, S.; Bodie, D.; Hayward, L.; Ferguson, M.; Campbell, L. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗